| Business Summary | | Cambrex
Corporation
primarily
provides
products
and
services
worldwide
to
the
life
sciences
industry.
The
Company
operates
in
four
segments,
consisting
of
Human
Health,
Biosciences,
Animal
Health/Agriculture
and
Specialty
and
Fine
Chemical.
The
Human
Health
segment
is
classified
into
eight
product
groups,
which
include
Active
Pharmaceutical
Ingredients,
Pharmaceutical
Intermediates,
Imaging
Chemicals,
Personal
Care
Ingredients,
Biomedical
Urethanes,
Catalysts,
Chiral
Technology
and
Nutraceuticals.
The
Biosciences
segment
consists
of
cell
culture
and
endotoxin
detection
products.
The
Animal
Health/Agriculture
segment
includes
vitamin
B-3,
agricultural
intermediates
and
animal
health
products.
The
Specialty
and
Fine
Chemical
segment
includes
performance
enhancing
chemicals
used
in
photography,
pigments,
specialty
polymers,
fuel/oil
additives,
catalysts
and
other
specialty
additives
and
polymer
systems
products
used
in
coatings,
telecommunications,
electronics
and
engineering
plastics. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Cambrex
Corporation
manufactures
and
markets
specialty
chemicals
and
fine
chemicals
as
well
as
products
and
services
to
the
life
sciences
industry.
For
the
six
months
ended
6/30/01,
net
revenues
fell
1%
to
$253.3
million.
Net
income
rose
10%
to
$29.2
million.
Revenues
reflect
a
decline
in
sales
at
the
Specialty
and
Fine
Chemicals
segment.
Earnings
benefitted
from
improved
gross
margins
due
to
increased
volume
and
favorable
product
mix,
and
reduced
debt
levels. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| James Mack, 63 Chairman,
CEO | $1.3M | $1.5M | Claes Glassell, 49 Pres,
COO, Director | 615K | 1.1M | Salvatore Guccione, 38 CFO | -- | -- | Steven Klosk, 43 Exec.
VP-Admin. | 543K | 759K | Peter Thauer, 61 Sr.
VP - Law & Environment, Gen. Counsel, Sec. | -- | -- | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|